KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Hims & Hers Health (HIMS) Return on Sales (2020 - 2025)

Hims & Hers Health (HIMS) has disclosed Return on Sales for 6 consecutive years, with 0.03% as the latest value for Q4 2025.

  • Quarterly Return on Sales fell 2.0% to 0.03% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.05% through Dec 2025, down 3.0% year-over-year, with the annual reading at 0.05% for FY2025, 3.0% down from the prior year.
  • Return on Sales hit 0.03% in Q4 2025 for Hims & Hers Health, up from 0.03% in the prior quarter.
  • In the past five years, Return on Sales ranged from a high of 0.19% in Q3 2024 to a low of 0.98% in Q1 2021.
  • Historically, Return on Sales has averaged 0.09% across 5 years, with a median of 0.03% in 2023.
  • Biggest five-year swings in Return on Sales: tumbled -78bps in 2021 and later soared 82bps in 2022.
  • Year by year, Return on Sales stood at 0.37% in 2021, then soared by 82bps to 0.07% in 2022, then surged by 108bps to 0.01% in 2023, then skyrocketed by 971bps to 0.05% in 2024, then crashed by -38bps to 0.03% in 2025.
  • Business Quant data shows Return on Sales for HIMS at 0.03% in Q4 2025, 0.03% in Q3 2025, and 0.08% in Q2 2025.